- Home
- ELLO vs TKNO Comparison
ELLO vs TKNO Comparison
Compare ELLO & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELLO | TKNO |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.4M | 268.1M |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELLO | TKNO |
|---|---|---|
| Price | $20.54 | $6.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.4K | ★ 251.3K |
| Earning Date | 03-31-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $17.00 | $1.91 |
| 52 Week High | $30.34 | $7.84 |
Technical Indicators
Market Signals| Indicator | ELLO | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 51.07 | 50.70 |
| Support Level | $18.03 | $4.87 |
| Resistance Level | $22.58 | $7.66 |
| Average True Range (ATR) | 0.88 | 0.37 |
| MACD | 0.13 | -0.12 |
| Stochastic Oscillator | 45.72 | 12.90 |
Price Performance
Historical ComparisonAbout ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions. Geographically, the company operates in segments: Italy; Spain; USA; Netherland and Israel. It derives maximum revenue from Spain.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.